StockWatch
·
HomeLiveWeekly
Pharmaceuticals
Management Change29 Apr 2026, 08:51 pm

RPG Life Sciences Appoints Dr. Samdani as Independent Director

AI Summary

RPG Life Sciences Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The Board also recommended a dividend of ₹24 per equity share (300%) for FY 2025-26, subject to shareholder approval. Dr. Pratit Samdani was appointed as an Additional Non-Executive Independent Director for a five-year term starting April 29, 2026. Additionally, the company amended its Code of fair disclosure for insider trading.

Key Highlights

  • Board approved audited financial results for Q4 and FY26.
  • Recommended a dividend of ₹24 per share (300%) for FY26.
  • Dr. Pratit Samdani appointed as Additional Non-Executive Independent Director for 5 years.
  • Company amended its Code of fair disclosure for insider trading.
View BSE Filing
RPGLIFE
Pharmaceuticals
RPG LIFE SCIENCES LTD.

Price Impact

More from RPGLIFE

Insider Trading25 Jun, 7:20 pm

RPG Life Sciences Closes Trading Window for Insiders

Dividend22 Jun, 6:51 pm

RPG Life Sciences Sets July 9 Record Date for FY26 Dividend

Clarification12 Jun, 2:59 pm

RPG Life Sciences Clarifies Volume Movement

More in Management Change

INDSOYA1d ago, 11:10 pm

Apollo Ingredients Appoints New Independent Director, Restructures MD/ED Roles

HDFCBANK1d ago, 10:40 pm

HDFC Bank Appoints New CFO-Designate and GC-Designate

KKALPANAIND1d ago, 9:10 pm

Kkalpana Industries: Independent Director Resigns, New Director Appointed